Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Economic Outcomes of Patients With Type 2 Diabetes Mellitus Initiating Bydureon and Glargine

NCT02843399 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02843399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02843399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Economic Outcomes of Patients With Type 2 Diabetes Mellitus Initiating Bydureon and Glargine
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 15, 2016
Completion date
December 15, 2016
Enrollment
15,498 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2